EVANSVILLE, Ind., Sept. 14, 2026 (GLOBE NEWSWIRE) — Old National Bank wants to make you aware of (and invite you to cover) our 5th annual Better Together Volunteer Days event.

WHEN: September 16-17, 2026 (see attached document for locations and times by state)
   
WHAT: Two days of team-focused volunteerism serving non-profit organizations. Team members
from across Old National’s footprint will be volunteering in four-hour shifts in the
communities where they live and work.
   
WHO: More than 2,000 Old National team members, executives and clients
   
WHERE: Approximately 200 volunteer locations in ten states of Florida, Illinois, Iowa, Indiana,
Kentucky, Michigan, Minnesota, North Dakota, Tennessee and Wisconsin
(see attached document for times and locations)
   
WHY:  Better Together Days allows Old National Bank to say thank you to the communities we serve. “Serving in our communities really keeps us grounded as a community bank with a mission to give back in the towns and cities we call home,” says Jim Ryan, Old National Chairman and CEO, who will be volunteering. “We’re proud of our team members for keeping service at the center of our culture and identity.”
   

Media event confirmations or post-event photos/video: Rick Vach, rick.vach@oldnational.com.

ABOUT OLD NATIONAL
Old National Bancorp (NASDAQ: ONB) is the holding company of Old National Bank. As the sixth largest commercial bank headquartered in the Midwest, Old National proudly serves clients primarily in the Midwest and Southeast. With approximately $74 billion of assets and $41 billion of assets under management, Old National ranks among the top 25 banking companies headquartered in the United States. Tracing our roots to 1834, Old National focuses on building long-term, highly valued partnerships with clients while also strengthening and supporting the communities we serve. In addition to providing extensive services in consumer and commercial banking, Old National offers comprehensive wealth management and capital markets services. For more information and financial data, please visit Investor Relations at oldnational.com. In 2026, Points of Light named Old National to “The Civic 50” for the third consecutive year – an honor recognizing the 50 most community-minded companies in the United States – and also named Old National the Financials Sector Leader among nominated banks and financial services organizations.

Media Relations:
Rick Vach
rick.vach@oldnational.com

比利時根特與東京–(BUSINESS WIRE)–(美國商業資訊)– H.U. Group Holdings Inc.及其全資子公司Fujirebio今日宣布,巴西衛生監管局(ANVISA)已核准Lumipulse G NfL Blood和Lumipulse G pTau 217 Plasma檢測,供巴西地區的全自動LUMIPULSE® G免疫分析平台使用。 Fujirebio Europe N.V.執行長Christiaan De Wilde表示:「ANVISA核准Lumipulse G NfL Blood和Lumipulse G pTau 217 Plasma檢測,是我們致力於讓全球臨床醫師和患者更容易取得可靠且具有臨床意義的血液生物標記又一項重要進展。透過在單一全自動平台上為實驗室提供這兩項神經生物標記檢測,我們協助在廣泛的神經疾病及整個診斷流程中,支援更完善的臨床決策。」 巴西ANVISA的核准是基於這兩項檢測已取得CE標誌並獲得體外診斷(IVD)核准,反映其符合不同監管機構的安全性和效能要求。本月稍早,這兩項檢測也獲得加拿大衛生部核發的Class II醫療器材許可證(M

LONDON–(BUSINESS WIRE)–  As Agent Bank, please be advised of the following rate determined on: 9/1/2026 Issue ¦ National Grid Gas plc – Series 46 GBP 25,000,000 Index Linked FRN due 30 Mar 2037     ISIN Number ¦ XS0281936889 ISIN Reference ¦ 28193688 Issue Nomin GBP ¦ 25000000 Period ¦ 9/30/2026 to 3/30/2027   Payment Date 3/30/2027 Number of Days ¦ 181 Rate ¦ 3.75473   Denomination GBP ¦ 50000   ¦ 25000000   ¦       Amount Payable per Denomination ¦ 938.68   ¦ 469341.12   ¦       Bank of New

SAINT-JEAN-DE-SOUDAIN, France–(BUSINESS WIRE)–Regulatory News: SergeFerrari Group (FR0011950682 – ALFER), l’un des leaders mondiaux dans les toiles composites innovantes, et coté sur Euronext Growth. Publication du nombre d’actions composant le capital et du nombre total de droits de vote (articles L. 233-8 II du code de commerce et 223-16 du règlement général de l’AMF). Date d’arrêt des informations Nombre total d’actions composant le capital Nombre total de droits de vote 31 août 2026 12 29

比利时根特与东京–(BUSINESS WIRE)–(美国商业资讯)– H.U. Group Holdings Inc.及其全资子公司Fujirebio今日宣布,巴西卫生监管局(ANVISA)已批准Lumipulse G NfL血液检测试剂及Lumipulse G pTau 217血浆检测试剂在巴西上市。这两款试剂盒均适用于全自动LUMIPULSE®G免疫检测平台。 Fujirebio Europe N.V.首席执行官Christiaan De Wilde表示,“巴西国家卫生监督局(ANVISA)批准Lumipulse G NfL血液检测试剂和Lumipulse G pTau 217血浆检测试剂,标志着我们在实现‘让全球临床医生和患者更广泛地获取可靠、具临床意义的血液生物标志物’这一使命的道路上又迈出了重要一步。通过在单一全自动平台上为实验室同时提供这两项神经系统生物标志物检测试剂,我们正在助力临床医生针对多种神经系统疾病,在整个诊断流程中做出更明智的决策。” 巴西国家卫生监督局(ANVISA)的授权基于这两项检测试剂已获得的CE认证体外诊断(IVD)批准,这表明其符合各监管机构的

Amundi: Launch of the capital increase reserved for employees

Amundi launches a capital increase reserved for employees (under the name We Share Amundi). This capital increase was initially decided on 2 February 2026 under the terms specified below.

This offer reflects Amundi’s desire to involve employees not only in the Company’s development but also in the creation of economic value. This will strengthen the employees’ sense of belonging.

The discount offered to employees will be 30%, as for the previous capital increase reserved for employees.

Eligible employees can subscribe to the offering between 14 September and 25 September 2026 included. The capital increase is scheduled for 22 October 2026 and the newly issued Amundi shares will be listed on Euronext Paris on 26 October 2026.

As a reminder, employees currently own 2.22% of Amundi’s share capital.

The impact of this offering on the net earnings per share should be negligible. The maximum number of Amundi shares to be issued will be capped at 1,000,000 shares (i.e. less than 0.5% of the Company’s share capital and voting rights).

Terms of the capital increase

Issuer

Amundi, a French limited company (société anonyme) with share capital of €515,965,815 and with its offices located at 91-93, Boulevard Pasteur, 75015 Paris, France, registered with the Paris Trade and Companies Registry under number 314 222 902 (the “Company”).

Securities offered

The offering is a capital increase in cash reserved for employees, employees who have taken early retirement and retired employees of Amundi Group companies that are members of the UES Amundi Company Savings Plan (“PEE”) or Amundi’s International Group Savings Plan (“PEGI”). The capital increase will be carried out pursuant to Resolution 27 of the Annual General Meeting of 27 May 2025, without preferential shareholder subscription rights.

The capital increase will be capped at 1,000,000 shares with a par value of €2.50 per share. The newly issued shares will be fully assimilated to existing ordinary shares.

Amundi will request that the newly issued shares under the offering be admitted for trading on Euronext Paris as soon as possible after the capital increase is completed, currently scheduled for 22 October 2026. These shares will be listed on the same line as the existing shares, under ISIN code FR0004125920.Terms of the 2026 offering
We Share Amundi is being made available to employees in France and Amundi Group entities in the following countries: Austria, Czech Republic, Germany, Hong Kong, Ireland, Italy, Japan, Luxembourg, Malaysia, Singapore, Spain, Switzerland, Taiwan and the United Kingdom.

Employees of companies that are members of the PEE or PEGI, with at least three months of employment, whether consecutive or not, between 1 January 2025 and the last day of the subscription period, as well as retired employees in France that have kept assets in the PEE, are eligible to the 2026 offering.

The subscription price is set at 66.63 euros. This subscription price is the average of the share opening price over the 20 trading days between 14 August and 10 September 2026 (included), minus a 30% discount.

Eligible employees can subscribe to the offering between 14 September and 25 September 2026 included.

Shares can be subscribed to via the FCPE (Employment Shareholding Fund) AMUNDI ACTIONNARIAT      RELAIS 2026 or FCPE AMUNDI SHARES RELAIS 2026, with the exception of certain countries where shares will be subscribed to directly. Once the capital increase is completed, and following decisions by the funds’ Supervisory Boards and the approval of the French Autorité des Marchés Financiers (AMF), the FCPE AMUNDI ACTIONNARIAT RELAIS 2026 will be merged into the FCPE AMUNDI ACTIONNARIAT, and the FCPE AMUNDI SHARES RELAIS 2026 will be merged into the FCPE AMUNDI SHARES.

The voting rights attached to the shares held via the Funds will be exercised by the Fund’s Supervisory Board. The voting rights attached to the directly-held shares will be exercised by the subscribers.

The shares subscribed to under We Share Amundi will be subject to a five-year lock-up period, unless an early-exit event occurs as described in the PEE or PEGI plan rules. Early-exit events will be adjusted where applicable for certain countries.

An employee can invest up to a maximum of €40,000. This cap is assessed on all the employee shareholding operations of the Crédit Agricole group in which Amundi employees could participate in 2026. Employees may finance their subscription by making voluntary contributions to the plans, up to the annual cap on investments in employee savings plans which is set at 25% of their gross annual compensation. Members of the UES Amundi PEE are also entitled to use their    assets held in another specific fund of the PEE.

Should subscription requests exceed the maximum number of shares available under the offering, the smallest subscriptions will be fully honoured while the highest subscriptions will be subject to successive caps until all available shares are subscribed. In France, any cap on subscriptions will first be applied to portions of subscriptions financed by voluntary contributions, then on the subscriptions financed by the transfer of available assets held in another specific fund of the PEE, and finally on the subscriptions financed by the transfer of unavailable assets held in another specific fund of the PEE.

Disclaimer

This press release is for information only and is not a solicitation to subscribe to Amundi shares.

We Share Amundi is strictly reserved to the eligible employees mentioned in this release and shall only be available in countries where such an offer has been registered with the competent local authorities, or the latter has been notified thereof, and/or following the approval of a prospectus by the competent local authorities, or if an exemption has been granted from the obligation to publish a prospectus or to register the offering with the authorities, or to notify the latter thereof.

More generally, We Share Amundi will only be available in countries where all required registration and/or notification procedures have been completed and the necessary authorizations obtained.

Contact

For any questions about We Share Amundi, eligible employees may contact their Head of Human Resources or visit the following website: https://weshare.amundi.com/2026/

***
About Amundi

Amundi, the leading European asset manager, ranking among the top 10 global players1, offers over 200 million investors a complete range of savings and investment solutions in active and passive management, in listed and private assets. Developed for a range of distributors (banks, wealth managers, financial advisors…) as well as for institutional investors and corporates, this offering is enhanced by services and technology tools covering the entire savings value chain. A subsidiary of the Crédit Agricole group and listed on the stock exchange, Amundi currently manages close to €2.6 trillion of assets2.
Its six international investment hubs3, its financial and extra-financial research capabilities and its long-standing commitment to responsible investment make Amundi a leading player in the international asset management landscape.
Thanks to its strong local presence, particularly in Europe and Asia, Amundi offers its clients the expertise and advice of 5,400 professionals across 34 countries.

Amundi, a trusted partner, working every day in the interest of its clients and society

www.amundi.com  

Press contacts:        
Natacha Andermahr 
Tel. +33 1 76 37 86 05
natacha.andermahr@amundi.com 

Corentin Henry
Tel. +33 1 76 36 26 96
corentin.henry@amundi.com

Investor contacts:
Cyril Meilland, CFA
Tel. +33 1 76 32 62 67
cyril.meilland@amundi.com 

Thomas Lapeyre
Tel. +33 1 76 33 70 54
thomas.lapeyre@amundi.com 

Annabelle Wiriath
Tel. + 33 1 76 32 43 92
annabelle.wiriath@amundi.com


1 Source: IPE “Top 500 Asset Managers” published in June 2026, based on assets under management as at 31/12/2025
2 Amundi data as at 30/06/2026
3 Paris, London, Dublin, Milan, Tokyo and San Antonio (via our strategic partnership with Victory Capital)

Attachment

BROSSARD, Quebec, Sept. 14, 2026 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related health pathologies using Artificial Intelligence (AI) techniques, announces that the 2026 annual general meeting of shareholders (the “Meeting”) will be held on September 30, 2026, at 10:00 a.m., in person, at Alt Quartier DIX30 Hotel, 6500 de Rome Blvd, 2nd floor, Brossard, QC, J4Y 0B6, for the following purposes:

  • To elect the directors of the Corporation;
  • To reappoint Raymond Chabot Grant Thornton, LLP, as independent auditor of the Corporation for the ensuing year and to authorize the directors to establish its remuneration; and
  • To transact such other business as may properly come before the Meeting.

Attendance and vote

All holders of common shares as of August 26, 2026 are entitled to attend and vote at the Meeting in person or by proxy. Instructions on how to vote can be found in the 2026 Management Information Circular which was mailed on September 3, 2026 and is available on www.sedarplus.com.

The Corporation encourages shareholders to vote early by following the instructions in the meeting materials mailed on September 3, 2026 along with the 2026 Management Information Circular. If you haven’t received your copy, please contact your stockbroker or Computershare Trust Company of Canada at 1-800-564-6253.

Extension of stock warrants exercise period

The Corporation would like to inform the stock warrants holders of the following series of the updated expiry dates.

Issuance date Number of stock warrants Expiry date (original) Expiry date (extended)
October 25, 2024 4,603,668 April 25, 2026 September 25, 2026
February 5, 2025 6,715,369 August 5, 2026 June 5, 2027
       

The exercise price remains unchanged at $0.40. For more information you can contact DIAGNOS at info@diagnos.com.

About DIAGNOS
DIAGNOS is a public Canadian corporation dedicated to the early detection of critical eye-related health problems. By developing innovative products based on AI technologies, DIAGNOS’ solutions provide healthcare clinicians with valuable information that refines diagnostic accuracy, streamlines workflows, and improves patient outcome.

Additional information is available at www.diagnos.com and www.sedarplus.com.

This news release contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements. DIAGNOS disclaims any intention or obligation to publically update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CONTACT: For further information, please contact:

Mr. Marc-André Massue
CFO and Secretary
DIAGNOS Inc.
Tel: 450-678-8882 ext. 235

LONDON–(BUSINESS WIRE)–  As Agent Bank, please be advised of the following rate determined on: 8/28/2026 Issue ¦ National Grid Electricity Transmission – Series 22 GBP 75,000,000 FRN Due 28 Sep 2035     ISIN Number ¦ XS0230845207 ISIN Reference ¦ 23084520 Issue Nomin GBP ¦ 75000000 Period ¦ 9/28/2026 to 3/28/2027   Payment Date 3/30/2027 Number of Days ¦ 181 Rate ¦ 4.515586   Denomination GBP ¦ 50000   ¦ 75000000   ¦       Amount Payable per Denomination ¦ 1128.9   ¦ 1693344.82   ¦       Bank

GENT, Belgien & TOKIO–(BUSINESS WIRE)–Die H.U. Group Holdings Inc. und ihre hundertprozentige Tochtergesellschaft Fujirebio gaben heute bekannt, dass die brasilianische Gesundheitsaufsichtsbehörde (ANVISA) die Marktzulassung für die Tests „Lumipulse G NfL Blood“ und „Lumipulse G pTau 217 Plasma“ zur Verwendung auf der vollautomatischen LUMIPULSE® G-Immunoassay-Plattform in Brasilien erteilt hat. „Die Zulassung der Tests Lumipulse G NfL Blood und Lumipulse G pTau 217 Plasma durch die ANVISA st

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.